Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: Implications for tumor angiogenesis

Molecular Oncology

Volumn 6, Issue 3, 2012, Pages 333-346

  Åkerblom, Björn ^a   Zang, Guangxiang ^a   Zhuang, Zhen W ^b   Calounova, Gabriela ^a   Simons, Michael ^b   Welsh, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b YALE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Insulinomas; Shb; VEGF

Indexed keywords

CD31 ANTIGEN; PROTEIN; SHB PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; INSULINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION; STAINING; TUMOR ANGIOGENESIS; TUMOR GROWTH; TUMOR MODEL; TUMOR VOLUME; WILD TYPE;

MUS;

EID: 84861458883     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.01.006     Document Type: Article

References (38)

1. Akerblom B., Barg S., Calounova G., Mokhtari D., Jansson L., Welsh M. Impaired glucose homeostasis in Shb-/- mice. J. Endocrinol. 2009.
2. Anneren C. Dual role of the tyrosine kinase GTK and the adaptor protein SHB in beta-cell growth: enhanced beta-cell replication after 60% pancreatectomy and increased sensitivity to streptozotocin. J. Endocrinol. 2002, 172:145-153.
3. Anneren C., Lindholm C.K., Kriz V., Welsh M. The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation. Curr. Mol. Med. 2003, 3:313-324.
4. Atwood W., Shah K. Polyomaviruses 2003, ENCYCLOPEDIA Of LIFE SCIENCES Copyright © 2003, John Wiley & Sons, Ltd. http://www.els.net, 10.1038/npg.els.0001082.
5. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2000, 2:737-744.
6. Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999, 284:808-812.
7. Calounova G., Livera G., Zhang X.Q., Liu K., Gosden R.G., Welsh M. The Src homology 2 domain-containing adapter protein B (SHB) regulates mouse oocyte maturation. PLoS One 2010, 5:e11155.
8. Casanovas O., Hicklin D.J., Bergers G., Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005, 8:299-309.
9. Chun M.G., Hanahan D. Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis. PLoS Genet. 2010, 6.
10. Compagni A., Wilgenbus P., Impagnatiello M.A., Cotten M., Christofori G. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res. 2000, 60:7163-7169.
11. Cross M.J., Lu L., Magnusson P., Nyqvist D., Holmqvist K., Welsh M., Claesson-Welsh L. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol. Biol. Cell 2002, 13:2881-2893.
12. Davoodpour P., Landstrom M., Welsh M. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein. BMC Cancer 2007, 7:161.
13. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 2004, 25:581-611.
14. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339:58-61.
15. Funa N.S., Kriz V., Zang G., Calounova G., Akerblom B., Mares J., Larsson E., Sun Y., Betsholtz C., Welsh M. Dysfunctional microvasculature as a consequence of Shb gene inactivation causes impaired tumor growth. Cancer Res. 2009, 69:2141-2148.
16. Funa N.S., Reddy K., Bhandarkar S., Kurenova E.V., Yang L., Cance W.G., Welsh M., Arbiser J.L. Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo. J. Invest. Dermatol. 2008, 128:710-716.
17. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 1984, 133:1710-1715.
18. Grant S.G., Seidman I., Hanahan D., Bautch V.L. Early invasiveness characterizes metastatic carcinoid tumors in transgenic mice. Cancer Res. 1991, 51:4917-4923.
19. Gustafsson K., Calounova G., Hjelm F., Kriz V., Heyman B., Gronvik K.O., Mostoslavsky G., Welsh M. Shb deficient mice display an augmented TH2 response in peripheral CD4+ T cells. BMC Immunol. 2011, 12:3.
20. Hagerkvist R., Mokhtari D., Lindholm C., Farnebo F., Mostoslavsky G., Mulligan R.C., Welsh N., Welsh M. Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli. Exp. Cell Res. 2007, 313:284-291.
21. Hakansson J., Xian X., He L., Stahlberg A., Nelander S., Samuelsson T., Kubista M., Semb H. Neural cell adhesion molecule-deficient beta-cell tumorigenesis results in diminished extracellular matrix molecule expression and tumour cell-matrix adhesion. Tumour Biol. 2005, 26:103-112.
22. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985, 315:115-122.
23. Herzig M., Savarese F., Novatchkova M., Semb H., Christofori G. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene 2007, 26:2290-2298.
24. Holmqvist K., Cross M., Riley D., Welsh M. The Shb adaptor protein causes Src-dependent cell spreading and activation of focal adhesion kinase in murine brain endothelial cells. Cell Signal. 2003, 15:171-179.
25. Holmqvist K., Cross M.J., Rolny C., Hagerkvist R., Rahimi N., Matsumoto T., Claesson-Welsh L., Welsh M. The adaptor protein Shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J. Biol. Chem. 2004, 279:22267-22275.
26. Inoue M., Hager J.H., Ferrara N., Gerber H.P., Hanahan D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell 2002, 1:193-202.
27. Karlsson T., Welsh M. Apoptosis of NIH3T3 cells overexpressing the Src homology 2 domain protein Shb. Oncogene 1996, 13:955-961.
28. Kriz V., Mares J., Wentzel P., Funa N.S., Calounova G., Zhang X.Q., Forsberg-Nilsson K., Forsberg M., Welsh M. Shb null allele is inherited with a transmission ratio distortion and causes reduced viability in utero. Dev. Dyn. 2007, 236:2485-2492.
29. Lopez T., Hanahan D. Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 2002, 1:339-353.
30. Lu L., Holmqvist K., Cross M., Welsh M. Role of the Src homology 2 domain-containing protein Shb in murine brain endothelial cell proliferation and differentiation. Cell Growth Differ. 2002, 13:141-148.
31. Medici D., Shore E.M., Lounev V.Y., Kaplan F.S., Kalluri R., Olsen B.R. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat. Med. 2010, 16:1400-1406.
32. Mokhtari D., Kerblom B., Mehmeti I., Wang X., Funa N.S., Olerud J., Lenzen S., Welsh N., Welsh M. Increased Hsp70 expression attenuates cytokine-induced cell death in islets of Langerhans from Shb knockout mice. Biochem. Biophys. Res. Commun. 2009.
33. Naik P., Karrim J., Hanahan D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 1996, 10:2105-2116.
34. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376:37-43.
35. Paez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Vinals F., Inoue M., Bergers G., Hanahan D., Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15:220-231.
36. Shoag J., Arany Z. Regulation of hypoxia-inducible genes by PGC-1 alpha. Arterioscler. Thromb. Vasc. Biol. 2010, 30:662-666.
37. Zagorchev L., Oses P., Zhuang Z.W., Moodie K., Mulligan-Kehoe M.J., Simons M., Couffinhal T. Micro computed tomography for vascular exploration. J. Angiogenes Res. 2010, 2:7.
38. Zhuang Z.W., Gao L., Murakami M., Pearlman J.D., Sackett T.J., Simons M., de Muinck E.D. Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents. Radiology 2006, 240:698-707.